Description

Levicitam 500 Coated Tablets 500 mg. №60

Ingredients

Each coated tablet contains 500 mg of Levetiracetam.

Dosage

The recommended dosage is as directed by a healthcare professional. It is usually taken orally with or without food, as prescribed.

Indications

Levicitam 500 is indicated for the treatment of epilepsy in adults and children. It is used to control seizures.

Contraindications

Do not use Levicitam 500 if you are allergic to levetiracetam or any other ingredients in the product. Consult your doctor for alternatives.

Directions

Swallow the tablet whole with a glass of water. Do not crush or chew the tablet. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence

Levetiracetam, the active ingredient in Levicitam 500, has been extensively studied for its efficacy in controlling seizures. Research published in the journal *Epilepsy Research* has shown that levetiracetam is well-tolerated and effective in reducing seizure frequency in patients with epilepsy.

Additional Information

It is important to take Levicitam 500 regularly to get the most benefit. **Do not stop taking the medication abruptly** without consulting your doctor, as it may lead to increased seizure activity. Inform your healthcare provider about all the medications you are currently taking to avoid any potential drug interactions.

Pharmacological Effects

Levetiracetam works by modulating neurotransmitter release, including inhibiting calcium channels and reducing the release of glutamate. This mechanism helps to stabilize electrical activity in the brain, reducing the likelihood of seizures.

Clinical Trials and Comparative Effectiveness

Clinical trials have demonstrated the efficacy of Levicitam 500 in reducing seizure frequency and improving quality of life in patients with epilepsy. Compared to traditional antiepileptic drugs, levetiracetam has shown similar efficacy but with a more favorable side effect profile, making it a preferred choice for many patients.

References:
1. Löscher W, et al. (2008). Efficacy and tolerability of levetiracetam in patients with therapy-resistant epilepsy. *Epilepsy Research*. 79(2-3): 124-132.